Alberto Mantovani, MD, is the scientific director of the Humanitas Research Hospital, president and founder of the Humanitas Research Foundation (Fondazione Humanitas per la Ricerca), and emeritus professor of pathology at Humanitas University, in Milan. He is also the Chair of Inflammation and Therapeutic Innovation at the William Harvey Research Institute of the Queen Mary University in London. He graduated summa cum laude in 1973 in Medicine at the University of Milan and in 1976 he specialized in Oncology at the University of Pavia. In 1979 he returned to Italy as a Senior Investigator at the Department of Tumor Immunology and Chemotherapy of the Istituto di Ricerche Farmacologiche “Mario Negri”, in Milan, where he became Chief of the Laboratory of Immunology in 1982 and Head of the Department of Immunology and Cell Biology in 1996. He has received several national and international awards, such as the Triennial OECI Award from the Organization of the European Cancer Institutes, the Robert Koch Award for his contribution to tumor immunology and immunotherapy, the American-Italian Cancer Foundation (AICF) Prize for Excellence in Medicine, the American Association for Cancer Research International Pezcoller Award for Extraordinary Achievement in Cancer Research, etc. His research activity has been focused on molecular mechanisms of innate immunity and inflammation.
Alberto Mantovani, MD, is the scientific director of the Humanitas Research Hospital, president and founder of the Humanitas Research Foundation (Fondazione Humanitas per la Ricerca), and emeritus professor of pathology at Humanitas University, in Milan. He is also the Chair of Inflammation and Therapeutic Innovation at the William Harvey Research Institute of the Queen Mary University in London. He graduated summa cum laude in 1973 in Medicine at the University of Milan and in 1976 he specialized in Oncology at the University of Pavia. In 1979 he returned to Italy as a Senior Investigator at the Department of Tumor Immunology and Chemotherapy of the Istituto di Ricerche Farmacologiche “Mario Negri”, in Milan, where he became Chief of the Laboratory of Immunology in 1982 and Head of the Department of Immunology and Cell Biology in 1996. He has received several national and international awards, such as the Triennial OECI Award from the Organization of the European Cancer Institutes, the Robert Koch Award for his contribution to tumor immunology and immunotherapy, the American-Italian Cancer Foundation (AICF) Prize for Excellence in Medicine, the American Association for Cancer Research International Pezcoller Award for Extraordinary Achievement in Cancer Research, etc. His research activity has been focused on molecular mechanisms of innate immunity and inflammation.